Evans C. Coutinho

Evans C. Coutinho

Auto-generated profile, based on publicly available information

Evans C. Coutinho

Bombay College of Pharmacy

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
JVJitender Verma
Jitender Verma
VKVijay Khedkar
Vijay Khedkar
ECEvans Coutinho
Evans Coutinho
Quantitative structure-activity relationships (QSAR) have been applied for decades in the development of relationships between physicochemical properties of chemical substances and their biological activities to obtain a reliable statistical model for prediction of the activities of new chemical entities. The fundamental principle underlying the formalism is that the difference in structural properties is responsible for the variations in biological activities of the compounds. In the classical QSAR studies, affinities of ligands to their binding sites, inhibition constants, rate constants, and other biological end points, with atomic, group or molecular properties such as lipophilicity, polarizability, electronic and steric properties (Hansch analysis) or with certain structural features (Free-Wilson analysis) have been correlated. However such an approach has only a limited utility for designing a new molecule due to the lack of consideration of the 3D structure of the molecules. 3D-QSAR has emerged as a natural extension to the classical Hansch and Free-Wilson approaches, which exploits the three-dimensional properties of the ligands to predict their biological activities using robust chemometric techniques such as PLS, G/PLS, ANN etc. It has served as a valuable predictive tool in the design of pharmaceuticals and agrochemicals. Although the trial and error factor involved in the development of a new drug cannot be ignored completely, QSAR certainly decreases the number of compounds to be synthesized by facilitating the selection of the most promising candidates. Several success stories of QSAR have attracted the medicinal chemists to investigate the relationships of structural properties with biological activity. This review seeks to provide a birds eye view of the different 3D-QSAR approaches employed within the current drug discovery community to construct predictive structure- activity relationships and also discusses the limitations that are fundamental to these approaches, as well as those that might be overcome with the improved strategies. The components involved in building a useful 3D-QSAR model are discussed, including the validation techniques available for this purpose.

1 January 2004 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
PDPrasanna Datar
Prasanna Datar
SSSudha Srivastava
Sudha Srivastava
ECEvans Coutinho
Evans Coutinho
GGGirjesh Govil
Girjesh Govil
Extensive efforts since 1931, on the structural determination of the mammalian tachykinin SP by NMR, CD and IR have turned out to be inconclusive. Studies are now being concentrated on the structural properties and characteristics of various NK receptors (NK1, NK2 and NK3) with the help of genetics, cloning, receptor engineering, mutagenesis and modeling. This knowledge is now being fruitfully used in the development of non-peptide NK1 receptor antagonists that essentially block the pharmacological effects of SP. It is now being realized that the simultaneous blockade of two or more receptors gives promising results in emesis, depression and pulmonary obstructive diseases. In addition to the synthetic compounds, the discovery of antagonists from natural origin has added a great value to this field. In this review we have made an attempt to present the structural characteristics of SP, its analogs and antagonists, the structural characteristics of the NK receptor, and structure activity relationships that have helped to improve the therapeutic utilities of SP antagonists.

1 March 2007 in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SKSantosh A. Khedkar
Santosh A. Khedkar
AMAlpeshkumar K. Malde
Alpeshkumar K. Malde
ECEvans C. Coutinho
Evans C. Coutinho
SSSudha Srivastava
Sudha Srivastava
Pharmacophore mapping is one of the major elements of drug design in the absence of structural data of the target receptor. The tool initially applied to discovery of lead molecules now extends to lead optimization. Pharmacophores can be used as queries for retrieving potential leads from structural databases (lead discovery), for designing molecules with specific desired attributes (lead optimization), and for assessing similarity and diversity of molecules using pharmacophore fingerprints. It can also be used to align molecules based on the 3D arrangement of chemical features or to develop predictive 3D QSAR models. This review begins with a brief historical overview of the pharmacophore evolution followed by a coverage of the developments in methodologies for pharmacophore identification over the period from inception of the pharmacophore concept to recent developments of the more sophisticated tools such as Catalyst, GASP, and DISCO. In addition, we present some very recent successes of the widely used pharmacophore generation methods in drug discovery.

1 January 2007 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
ANAmit Nayyar
Amit Nayyar
VMVikramdeep Monga
Vikramdeep Monga
AMAlpeshkumar Malde
Alpeshkumar Malde
ECEvans Coutinho
Evans Coutinho
RJRahul Jain
Rahul Jain

15 September 2011 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
AJAnkitkumar S. Jain
Ankitkumar S. Jain
ADAbhijit A. Date
Abhijit A. Date
RPRaghuvir Pissurlenkar
Raghuvir Pissurlenkar
ECEvans C. Coutinho
Evans C. Coutinho
MNMangal S. Nagarsenker
Mangal S. Nagarsenker

1 January 2012 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RKRanjan C. Khunt
Ranjan C. Khunt
VKV.M. Khedkar
V.M. Khedkar
RCR.S. Chawda
R.S. Chawda
NCN.A. Chauhan
N.A. Chauhan
APA.R. Parikh
A.R. Parikh
ECE.C. Coutinho
E.C. Coutinho